View More Recent Stories
-
Merus N.V. (MRUS) PT Raised to $95 at BMO Capital
-
Merus N.V. (MRUS) Misses Q2 EPS by 5c
-
RBC's biotech survey shows investors more bearish vs. last time
-
Merus N.V. (MRUS) Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer
-
Merus N.V. (MRUS) PT Raised to $93 at Citi
-
Merus N.V. (MRUS) PT Raised to $99 at Stifel

